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THE PRESENT SEMI-ANNUAL REPORT CONSISTS OF TWO PARTS 
PART ONE: The preliminary data e s s e n t i a l  for the experiments 
w i t h  animals placed i n  a simulated high a l t i t u d e  a i r  
chamber. This data  r e l a t e s  t o  the blood sero tonin  
c o n c e n t r a t i o n  i n  normal  animals of var ious genera 
which w i l l  be used i n  our  experiments w i t h  h igh  
a l t i t u d e  a i r ,  the dev ia t ions  i n  blood sero tonin  con- 
c e n t r a t i o n s  under var ious abnormal condi t ions,  such 
as  cancer and hypercholesteremia, a s  w e l l  a s  some 
data of blood concentrat ion i n  normal men and 
cardiac pa t i en t s .  
PART TWO: The effect of s i m u l a t e d  high a l t i t u d e  a i r  on blood 
sero tonin  and serum ascorbone concentrations.  
R e m a r k :  The tests on serum ascorbone concentrat ion are 
included i n  t h i s  study because it w a s  found tha t  
there seems t o  be some i n t r i n s i c  r e l a t i o n s h i p  between 
sero tonin  and ascorbone levels, a n  i n d i c a t i o n  tha t  
the ascorbic ac id  metabolism seems t o  be altered i n  
cases of elevated blood sero tonin  concentration. 
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INTRODUCTORY 
SEROTONIN 
During the l a s t  decade, a great deal of attention has been 
given i n  t h i s  country and abroad t o  the biologic activity of 
serotonin, a metabolite , otherwise known as 5-hydroxytryptamine 
( 5 - H T ) ,  
of physiological phenomena, including glandular function, 
specifically adreno-cortical hormones, inflammation, and 
vascular and cellular pe rmeabil i ty  . 
The activity of t h i s  metabolite covers a large f ie ld  
I n  their classic study, Majno and Palade, us ing  the electron 
microscope, demonstrated that serotonin played an important role 
i n  the increase of vascular permeability. I n  fact ,  serotonin 
w a s  found more potent i n  th is  respect than histamine, on a 
mole-to-mole basis. The investigators, d i scuss ing  the patho- 
genesis of the endothelial leaks, stressed the fact  that  the 
electron microscopic findings suggested that the endothelial 
c e l l s  became partially disconnected along the intercellular 
junction, w i t h  numerous endothelial openings, through which the 
molecules of protein and l i p i d  were able t o  pass, Majno e t  a l ,  
pointed out that  the leaking vessels always belonged t o  the 
venous side of the circulation, The heaviest deposits were 
found i n  venules 10 t o  20 micra i n  diameter. Frimmer investi- 
gated the effect  of subcutaneous injection of 5-HT on capillary 
permeability. He found that the permeability rate for large 
,i / 
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c o l l o i d a l  molecules w a s  considerably increased. Jenkins  e t  a l .  
observed a n  increase  i n  the c e l l u l a r  membrane permeabi l i ty  
a f t e r  5-HT appl ica t ion .  Cater described marked changes i n  t h e  
blood pressure,  with p a r a l l e l  changes i n  O2 tension,  i n  p a t i e n t s  
a f f ec t ed  wi th  malignant tumors and rece iv ing  5-HT. This phen- 
omenon ind ica ted ,  according t o  C a t e r ,  t h a t  t h e r e  w a s  very 
l i t t l e  l o c a l  masomotor control over tumor blood flow. Sullen- 
berger  e t  a l .  observed t h a t  i n  i n t r avascu la r  thrombosis t h e r e  
was a s i g n i f i c a n t  e l eva t ion  of blood 5-HT, and a n  increased 
excre t ion  of 5-hydroxy-indoleacetic acid i n  urine.  Labend- 
z i n s k i  and B i e l s k i  disclosed t h a t  there seemed t o  be a s ign i -  
f i c a n t  i n f h e n c e  of 5-HT on the blood c l o t t i n g  system. Spaziani  
reported t h a t  adminis t ra t ion  of 5-HT c r e a t i n i n e  s u l f a t e  t o  
female ra t s  produced a considerable increase  i n  u t e r i n e  w a t e r  
content. According t o  Markiewicz, 5-HT i n j e c t e d  subcutaneously 
t o  dogs produced a n  adrenergic  and cho l ine rg ic  effect on blood 
f a t  content. Waugh and Beschel and Waugh and Pear l  reported 
tha t  5-HT, i n j e c t e d  i n t r a p e r i t o n e a l l y  i n  s m a l l  doses, induced 
i n  r a t s  r e n a l  ischemia, w i t h  the lesions of a t r a n s i e n t  nature ,  
bu t  l a r g e r  doses of t h e  metabolite (up t o  150 mg./kg.wt.) 
r e s u l t e d  i n  acute  nephrosis and r e n a l  c o r t i c a l  necros is ,  and 
occas iona l ly  a l s o  foca l  necros is  of t h e  liver. Z i e m l a n s k i  
found that  s m a l l  doses of 5-HT increased and larger doses 
markedly i n h i b i t e d  sec re t ion  of gastric j u i c e  i n  dogs. A d a m s  
j ?/ 
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d iscovered  t ha t  large doses  of 5-HT admin i s t e red  dur ing  preg- 
nancy, might produce a b o r t i o n ,  w h i l e  smaller doses  might cause 
anomalies i n  babies, 
Remark: The vascular permeability and body dehydra t ion  caused 
by se ro ton in  deserves  par t icular  a t t e n t i o n ,  
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ASCORBONE 
I n  our preliminary experiments we estimated the serum 
ascorbic concentration. Here w e  came t o  an unexpected phen- 
omenon. The animals or men who have an elevated blood sero- 
tonin concentration contained a large amount of dehydroascorbic 
acid, otherwise known as  ascorbone. Accordingly, i n  our more 
recent tes ts ,  we estimated both TAA ( to t a l  ascorbic acid) and 
ascorbone. 
A basic fact  about ascorbic acid metabolism i n  the human 
or animal body was, for a number of years,misunderstood. For 
it was believed that Vitamin C exis ts  i n  plasma i n  the reduced 
form of ascorbic acid. More recently, it was proved not t o  be 
so. Stewart e t  a l .  demonstrated t h a t  i n  certain conditions, a 
significant pa r t  of ascorbic acid i n  plasma was i n  the form of 
dehydroascorbic acid otherwise known as  ascorbone. Patterson 
established the relationship between ascorbone and experimental 
diabetes. 
acid should be called ascorbone. Patterson and Mastin have 
shown t ha t  ascorbone is  highly toxic when given intravenously, 
causing hypertension i n  r a t s  i n  doses as low as 5 rg./kg.wt., 
and that it might cause atrophic changes i n  the f u r ,  l iver  and 
death i n  large doses. According t o  Raiha, ascorbone i s  ten 
times as f a t  soluble a s  ascorbic acid. 
that  i n  coronary and related diseases the concentration of 
Lloyd and Sinclair suggested that dehydroascorbic 
Sokoloff e t  al .  reported 
/ 
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0 ascorbone i s  about t h r e e  f o l d  h ighe r  than i n  healthy persons of 
the  same age group, McGraw and Desmarais, S lusher  and R o b e r t s ,  
McGraw, Stewart  e t  a l , ,  H a r r i s  e t  a l , ,  Khlalil and o t h e r s  
s t r e s s e d  t h e  fact  that  the m e t a b o l i s m  of ascorbic a c i d  is  
inf luenced by c o r t i c a l  hormones, and it has an  adversary effect 
on t h e  func t ions  of t h e  s m a l l  blood vessels, par t icular ly  of 
the capillaries,  
B 
Our experiments on ra t s ,  i n j e c t e d  wi th  5-hydroxytryptamine 
c r e a t i n i n e  su l fa te  have demonstrated tha t  such a t r ea tmen t  
r e s u l t e d  i n  t h e  appearance of ascorbone i n  large quant i t ies ,  
The d a t a  of t h i s  experimentation is repor t ed  i n  Tables 
1-4, 
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BLOOD SEROTONIN AND URINE 5-NIAA 











Normal r a t s  
Normal gulnea plgs  
Normal r a b b l t s  
Normal chlcks 
Cancerous r a t s  
Norma 1 humans 
Cardlac humans 
Humans su f fe r lng  f rom v e r t l g o  
Hypercholes teremlc r a b b l t s  
Hypercholesteremlc r a t s  
Hypercholesteremlc r a b b l t s  glven ascorb lc  ac ld  
Hypercholesterenilc r a t s  glven ascorb lc  ac ld  
Cardlac p a t l e n t s  rece lv lng  heavy doses of 
ascorb lc  ac ld  
No. 17 
March 1 - 5 ,  1966 
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Average welght gm. Average concentrat lon o f  se ro tonln  
I n  the blood, r / m l  
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Average welght'  gm. 
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823 . 18 
. 14 
13 . 26 . 20 
15 
Average concentrat lon of serotonln 
l n  the blood, T / m l  
.18 - 
No. 21-3 
A p r l l  6 - 13, 1966 
C H I C K S  
Baby chlcks.  hea l thy  

















Average body welght  Average concentrat ion of se ro tonln  
gm. I n  b lood ,  y- ' /ml 
L a  2.39 
Adult c h l c k s .  heal thy 
1850 2.65 
2145 3.12 
22 59 2.25 
2340 3.35 
2450 2.94 
Average body welght  Average concent ra t lon  of se ro tonln  
m. I n  blood, r / m 1  
2209 2.86 
Narch 5 - 15, 1966 
RA TS 
Young r a t s .  heal thy,  males 

















. l a  
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19 
Average we:ght gm, Average concentrat ion of se ro tonln  
I n  the blood, mal 
64.4 - 22 









.24 . 17 
26 
.2a 
15 . 12 . 14 
.18 . 22 
17 
Average weight gm. Average concentrat ion o f  se ro tonln  
I n  the blood, .$/a1 
194 .le 
A p r l l  5 - 9, 1966 
GUINEA PIGS 
Young rn €nea DIES. males 
Body welght, gm. Blood serotonln concentratlon, p / m l  










Average bridy w t .  Average concentratlon of sero tonin  
In the blood,  r/ml 
327 - .28 
No. 21-1 
March 18 - 23, 1966 
RABBITS 
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i n  blood, Z P / m l .  
Average w e  lgh t gm . 
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Average concentrat lon of se ro tonin  
In  blood, f/ml. 
2423 
No. 18-3-4 
A p r l l  2- 18, 1966 
FLEXNER BAT CARCINOMA 
Blood Serotonln before and a f t e r  t ransplan ta t lon  of the tumor, 
Rat Before Days a f t e r  T,ansplantatlon 
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Avg . . 24 . 387 . 465 
NO. 19-3 
March 6 - 20, 1966 
FLEXNER RAT CARCINOMA 
Blood Serotonln before and a f t e r  t ransplan ta t lon  of t h e  
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. 2’78 .296 . 564 
Tumor w t .  
gm. 12 days 












Blood Serotonln Humans, d " / l O O  m l .  
KL, age 25 l3.2 
PJJ, age 35 18.5 
TS, age 41 '7. 3 
NM, age 22 l48 3 
LCS, age 43 21.2 
OK, age 39 16.5 
WS, age 49 20.2 
DR, age 47 26.4 
WH, age 52 '9.9 
LJK, age 33 '7.7 
ME, age 22 14.8 
HE, age 55 22.3 
HJ, age 35 17.6 
AC, age 37 
TM, age 59 
NG, age 63 
IS, age 66 
NS,  age 64 
BB, age 68 
TF, age 65 
BG, age 6ii. 
JKK, age 57 
J N ,  age 69 
RV, age 66 








Comment: There I s  a s l l g h t  trend, In  otherwlse heal thy 
humans t o  Increase serotonin concentratlon In 
the Ir blood 
October 1964 - September 1966 
Blood Serotonln In Cardlac Pa t len ts ,  8/100. m l  
Cardlac DatZents wl th  low LPL 
0 
AN, age 54 32.3 
SS, age 52 37.2 
RS, age 62 34.2 
LP, age 55 29.4 
J T ,  age 66 38.8 
SD, age 56 25.4 
LO, age 57 39.2 
DR, age 50 29.9 
IG, age 58 37.7 
C-T, age 57 35.4 
GK, age 69 39.2 
BL, age 64 33.2 
TM, age 59 37.5 
FD, age 64 23.5 
S?,  age 46 - 36.6 
E.L., age 53 37.7 
DF, age 68 41.2 
XH, age 55 b0.5 
)E, age 56 38.8 
LD, age 62 24.2 
AS, age 56 
?P, age 65 
LP, age 49 






Comment: The cardlac p a t i e n t s  show an elevated concentrat lan , 
of  serotonln In blood, w l t h  very few exceptlons. 
0 
#11-14-B-123, T.M. 
August 1965 - August 1966 
B l o o d  Serni;or?ln the  Pa t len ts  w l t h  Vertlno, Y / 1 0 0  m l  
G I ,  age 42, Vertlgo Grade I 
A S ,  age 52, Vertigo Grade I1 
GK, age 62, VertPgo Grade III 
Li4, age 39, V, r t lgo  Grade I11 
AK, age 314, Vertlgo Grade I V  
EB, age 55, Vertigo Grade I11 
LS, age 32, V s r t l g o  Grade I V  









There IS sGme tendency t o  a hlgher concentratlon o f  serotonln 
i n  the blood of pa t f en t s  a f fec ted  w l t h  vertlgo. 
Not conciuslve:  t o o  s'mall scale  a t r Ia1.  
BPIEF SUNNARY 
(1) Oxt of  ma-ny ge%era and spec le s  o f  anlrnals, two genera 
show a very hC,gh concent ra t lon  o f  blood sero tonln :  
r a b b l t s  Ecd chlcks .  Bo th  of  these  animals have a 
very  pronounced tendency t o  form atheromatous les lons .  
( 2 )  Hea22hy men show an I n s i g n i f i c a n t  dev la t lon  In  blood 
se ro ton ln  concentratxon, a l though wlth ag ing  some 
t rend i s  observad t,j Z x r e a s e  S l o o d  serotoylln con- 
cen t r a t ion .  
(3 ;  Cardzac p a t i e n t s  manlfest ,  a s  a r u l e ,  a hfgher  blood 
concent ra t ion  of se ro tonln ,  although some except lons 
were observed from t h i s  gene ra l  r u l e .  
A small s c a l e  I n v e s t i g a t i o n  of t h e  p a t l e n t s  a f f e c t e d  
w€th v e r t l g o  seems t o  lndlcate  t h a t  t h e l r  blood sero- 
( 4 )  
ton:n concent ra t fon  is somewhat h lgher  than  i n  normal 
persorls. 
On t h e  basis of the data thus  reported:  
ijlood Se:mtonin Concentration 
Average for  m i c e :  -158 ar , i  .18 unit/ml. 
Average f o r  chickens: 
Average for rats:  -22 and .19 unit/ml. 
2.39 and 2.86 unit/ml. 
Average foz guinea p i g s  : - 2 8  unit/ml. 
Avzrage for  rabbits: 
Avsxage for  cancerous racs: 
1.15 and 1.775 unit/ml. 
,465 uriit/ml, 
Average for ckncerous tunox rata: ,564 unit/ml, 
Kuman blood se ro ton in  concentrat ion:  be tween 13.2 and 26.4 
unit/100 m l .  
Cardiac p a t i e n t  blood sero tonin  concent ra t ion :  between 24.5 
and 41.2 unif l00 ml. 
. 
Blood serotol i in  concent ra t ion  i n  p a t i e n t s  a f f e c t e d  w i t h  ve r t igo :  
between 24.4 and 35.5 
unit/100 m l ,  
EFFECT OF HYPERCHOLESTEREMIA ON BLOOD SEROTONIN CONCENTRATION 
0 An extensive invest igat ion was conducted for seven months 
on the possible effect of choles te ro l  feeding on blood serotonin 
concentration i n  rabbits. I n  this series 86 rabbits served as 
control, 105 rabbits were f e d  cholesterol, 200 mg./kg.wt./day 
for 6-7 months and 112  rabbits were fed cholesterol, 200 mg./ 
kg.wt./day and given 250 nrg./kg.wt./day ascorbic acid for 6-7 
months. 
The resul ts  of t h i s  experimentation has shown that: 
Average blood serotonin concentration of 86 con t ro l  
rabbits wa8: 1.498. 
Average blood serbtonin concentrat ion of 105 cholesterol 
fed rabbits was: between 2.83 and 4.71 unit/ml, depending on 
the blood to ta l  cholesterol level. 
Average blood serotonin concentrat ion of 112 cholesterol 
fed rabbits, 200 mg/kg.wt./day, receiving ascorbic acid, 250 
mg./kg.wt./day w a s  between .98 and 1.94 unit/ml. depending on 
the blood total  cholesterol level. 
Conclusions: (A )  Hypercholesteremia tends t o  increase 
the blood serotonin concentration. 
(B) Ascorbic acid given simultaneously w i t h  choles te ro l  
t o  rabbits tends t o  decrease s ign i f i can t ly  the blood serotonin 
concentration. 
The records of a l l  individual  rabbit tests are available 




In the present study, the effeot of cholesterol-feedlng 
on blood serotonln and urlne 5-HIM ooncentratlon me 
lnves t lga ted. 
86 rabblltS- served a s  control: 
Average tota l  serum cholesterol, mg/dl: 
Average blood serotonln content, unlt/ml. : 
61.6 
1.498 
Average Urine 5-HIM.concentratlo11, unlt: 05036 
Average Llpoproteln Llpase serum aotlvlty,  unlt: . 577 
Average Body welght, e.: 2280 
e -  
/ 
- EFFECT OF HYPERCHOLESTEREMIA I N  RABBITS 
ON SEROTONIN CONCENTRATION I N  THEIR BLOQD 
AND ON THE ACTIVITY OF LIPOPROTEIN LIPASE 
A l l  rabblts were fed cholesterol,  from 150 t o  200 
mg/kg.wt./day for several months, 
three-four months of feedlng, a change In serotonln 
concentratlon In blood was observed, 
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EXPLANATION OF TABLE I 
Rabblt Fed Cholesterol. 200 mdkn.wt./daY 
Total Chol. No. of 

























































Feedlng rabblts wl th  c h o l e s t e r o l ,  100-200 mg/kg. w t .  /day 
f o r  6-8 months, no t  only Increases  t h e  blood t o t a l  c h o l e s t e r o l  
from the average normal l e v e l  of 5-75 mg/100 m l .  U p  t o  
800-1400 mg/100 m l .  b u t  a l s o  suppresses  t h e  a c t l v l t y  of 
l l p o p r o t e l n  l l p a s e ,  from the  normal l e v e l  of about  .600 
unlt/ml. to 250 u n l t s  o r  less, and Increases t h e  blood 
concent ra t lon  of serotonin from an average 1.2 unlt/ml. 
t o  about 4.0 unlt/ml. 
\ 
! 
THE INFLUENCE OF HEAVY D O S E ,  LONG RANGE ASCORBIC A C I D  
THERAPY ON THE TOTAL CHOLESTEROL, L I P O P R O T E I N  L I P A S E  
A C T I V I T Y ,  BLOOD S E R O T O N I N  CONCENTRATION AND URINE 
~ - H I A A  CONCENTRATION IN RABBITS FED CHOIESTEROL 
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EXPLANATION OF TABLE I1 
Total ChOlm No.Of A v g .  Tota l  A v e r a g e  
mg/100 ml, Rabblts Cholesterol Se ro t onln 
48-98 7 84,6 0.98 
106.196 39 146.0 1.17 
mg/100 ml. un:/ml 
204-250 24 227,8 1 469 











Ascorblc acid, glven t o  the rabblts fed cholesterol, 
200 rng/kg.wt./day, In  the amount of 250 mg/kg.wt./day, 
decreased drast lcal ly  the blood t o t a l  cholesterol from 
800-1200 mg/100 m l .  a t  the end of slx-elght months of 
feedlng, t o  an average 300-350 mg/lOO m l .  It stlmulated 
the ac t lv l ty  of 1lpoproWn llpase almost t o  I ts  normal 
blood concentratlon, .450-.5OO unltlml, and decreased 
/ 
conslderably the blood concentratlon of serotonln, down 
t o  1.5.1.6 unlt/ml, the metabollte normal level In rabblts. 
i 
EFFECT OF 5-HYDRCUCYTRYPTAMINE CREATININE SULFATE (5-HT) 
ON SERUM ASCORBONE CONCENTRATION I N  RATS 
SEROTONIN AND ASCORBONE 
I n  our previous experiments we reported that after 
repeated injections of serotonin, 5-HT creatinine sulfate for 
5-7 days, 40 mg./kg.wt./day/rat, certain s y m p t o m s ,  vertigo- 
like, were observed, 
was noticed i n  8- animals, Besides checking the serum 
serotonin level i n  animals, we determined their serum ascorbic 
acid. Normal rats, or rabbits, never contain i n  their serum 
the oxidized form of ascorbic acid, dehydroascorbic acid, 
known as ascorbone, However, i n  certain conditions, speci- 
f ically when the serotonin level is elevated (or in grave 
f a t  metabolism disturbances), we found the presence of ascor- 
bone i n  a relatively large amount, often up t o  25% of the 
total  ascorbic acid. 
Also, an increased apathy (or fatigue) 
The following tables summarize the results of our pre- 
liminary tests which are now being repeated on a larger scale, 
TABLE I 
Normal rats. Serum serotonin and ascorbone concentration 
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In  normal rats, no reduced f o r m  of 
detectable, except traces i n  t w o  cases. 
ascorbic acid is 
TABLE I1 
Serotonin treated rats, Total dose: 280 mg./ kq .wt  ,/rat 
Serum serotonin and ascorbone concentrat ion 
Average weight 137 gm, 
T o t a l  Ascorbic Ascorbone Serotonin 





















In  serotonin treated rats, a part of ascorbic acid appears 
/ 
i n  the form of i ts  reduced form, ascorbone, In some animals 
25 or more % of total  ascorbic acid is i n  the form of ascorbone, 
TABLE I11 














mg./lOO m l ,  
No presence of ascorbone w a s  detected i n  normal rabbits, 
except a small trace i n  one case. 
TABLE I V  
Serotonin treated rabbits. Total  dose: 280 m./ kg ,wt,  /rabbit 
Serum serotonin and ascorbone concentrat ion 
Serotonin Total Ascorbic Ascorbone 
unit/ml, A c i d .  mO/ 100 ml, mgO/lOO m l ,  
10 
2. 


















In serotonin treated rabbits serum, ascorbone is present  
i n  the concentration f r o m  20 to  25%. There are s igns  i n  / 





From our pre l iminary  study, we arrived a t  the conclusion 
tha t  rats seem t o  be the best subjec ts  for experiments w i t h  
high altitude air. A r a t  is very similar i n  i t s  physiology 
and metabolic factors t o  man, A normal r a t  has a rather laJ 
blood serotonin concentration and it is q u i t e  constant,  
unless  there are present  some abnormal condi t ions,  such as 
cancer or a disturbance of f a t  m e t a b o l i s m  factors, Its 
average blood serotonin concentration is .l8 - .3 ,  and any 
s ign i f i can t  increase i n  the blood serotonin levels i s  c l e a r l y  
determined. Furthermore, for more than  three years we have 
been invest igat ing i n  rats var iaus  factors, enzyme and f a t  
m e t a b o l i s m  factors, and have considerable and well-standardized 
methods. A l l  t h i s  i s  very Important when we shall  start t o  
try var ious ant i -serotonin (ant imetabol i tes)  agents  i n  order 
to prevent the increase i n  blood serotonin levels at high 
a l t i t ude .  Technically rats offer an easy subjec t  too. W e  
are able t o  test per week, 24 r a t  blood or about 100 ra t s  per 
month. 
for exact r e s u l t s  than rabbits w i t h  their very high na tu ra l  
blood serotonin. It is  e s s e n t i a l  that the blood be taken 
immediately after the rats are removed f r o m  the chamber. 
A t  30,000 feet al t i tude,  they show s igns  of vertigo and 
+ 
/ 
In  th i s  respect rats offer a much better opportani ty  
i 
I 
also of considerable dehydration. We have not  yet started 
t o  collect their urine,  but  we are planning t o  do th i s  a f te r  
a s u f f i c i e n t  number of tests have been conducted. 
On the other hand, rats d i f fe r  from man i n  the ab i l i t y  
t o  produce ascorbic acid and therefore the data we are now 
collecting on the effect of simulated high a l t i t u d e  a i r  on 
ascorbone is only of relative value. For  t h i s  reason, we  
are planning also t o  use guPnea pigs, who  are unable, l i k e  
man, t o  produce ascorbic acid. 
Thus ais fa r  as our  cur ren t  study is concerned, we intend 
t o  use for our experiments only ra ts  and guinea pigs. 
In  order to  obtain a s u f f i c i e n t  amount of blood, both 
ra t s  and guinea pigs are ki l led,  w i t h  blood taken f r o m  their 
heart. 
/ 
EFFECT OF SIMULATED HIGH ALTITUDE AIR OI BLOOD 
SEROTO K I N  CONCENTBILTIO N 
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EFFECT OF SIMULATED HIGH ALTITUDE A I R ,  30,000 F E E T  ON BLOOD 
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EFFECT OF SIMULATED HIGH ALTITUDE A I R  ON BLOOD SEROTONIN 
CONCENTRATION AND SERUM ASCORBONE CONCENTRATION. 
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EFFECT OF SIMULATED HIGH ALTITUDE AIR ON BLOOD SEROTONIN 
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Test #9 NASA Project  
Survlval test for gulnee plg.  













EFFECT OF SIMULATED HIGH ALTITUDE AIR, 30,000 FEET ON BLOOD 
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SIMULATED HIGH ALTITUDE A I R ,  30,000 FEET ON BLOOD 
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S UMMAR Y 
of 
PART I1 
The prellmlnary t e s t s  wl th  a slmulated h lgh  a l t l t u d e  
a l r  chamber lnd lca te  t h a t  the blood serotonln concentratlon 
In r a t s  was s l g n l f i c a n t l y  increased a t  30,000 f ee t .  
increase was much less pronounced a t  the a l t l t u d e  of 20,000 
fee t .  
T h l s  
Extenslve t e s t s  wl th  r a t s ,  a s  well  as wl th  gulnea 
pigs  and r a b b l t s  w l t h  simulated h l g h  a l t l t u d e  a l r ,  both 
on blood serotonln concentration and plasma ascorbone 
concentrat ion w l l l  be conducted durlng the next months. 
